Cobalt should be bought on any weakness on test results, says Stifel Nicolaus

Stifel Nicolaus believes that negative results from Cobalt's drill-stem test of its Cameia #2 appraisal well could place further pressure on the stock. The firm thinks that such weakness would create an attractive risk/reward ratio in light of the company's upcoming catalysts, and it maintains a Buy rating.

Advertisement